COMAL SPA (CML.MI) Fundamental Analysis & Valuation

BIT:CML • IT0005428971

5.08 EUR
0 (0%)
Last: Mar 17, 2025, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This CML.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Overall CML gets a fundamental rating of 5 out of 10. We evaluated CML against 73 industry peers in the Electrical Equipment industry. CML scores excellent on profitability, but there are concerns on its financial health. CML is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

7

1. CML.MI Profitability Analysis

1.1 Basic Checks

  • CML had positive earnings in the past year.
  • In the past year CML has reported a negative cash flow from operations.
  • Each year in the past 5 years CML has been profitable.
  • In the past 5 years CML reported 4 times negative operating cash flow.
CML.MI Yearly Net Income VS EBIT VS OCF VS FCFCML.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 5M -5M -10M

1.2 Ratios

  • CML has a Return On Assets of 1.83%. This is comparable to the rest of the industry: CML outperforms 59.62% of its industry peers.
  • Looking at the Return On Equity, with a value of 20.81%, CML belongs to the top of the industry, outperforming 90.38% of the companies in the same industry.
  • The Return On Invested Capital of CML (14.56%) is better than 94.23% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CML is in line with the industry average of 9.64%.
  • The 3 year average ROIC (10.49%) for CML is below the current ROIC(14.56%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.83%
ROE 20.81%
ROIC 14.56%
ROA(3y)2.62%
ROA(5y)2.89%
ROE(3y)17.19%
ROE(5y)19.48%
ROIC(3y)10.49%
ROIC(5y)12.54%
CML.MI Yearly ROA, ROE, ROICCML.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 10 20 30

1.3 Margins

  • Looking at the Profit Margin, with a value of 6.97%, CML belongs to the top of the industry, outperforming 86.54% of the companies in the same industry.
  • CML's Profit Margin has improved in the last couple of years.
  • CML has a Operating Margin of 14.12%. This is amongst the best in the industry. CML outperforms 90.38% of its industry peers.
  • CML's Operating Margin has improved in the last couple of years.
  • With a decent Gross Margin value of 44.47%, CML is doing good in the industry, outperforming 65.38% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CML has grown nicely.
Industry RankSector Rank
OM 14.12%
PM (TTM) 6.97%
GM 44.47%
OM growth 3Y5.5%
OM growth 5Y21.44%
PM growth 3Y7.89%
PM growth 5Y26.25%
GM growth 3Y9.58%
GM growth 5Y17.09%
CML.MI Yearly Profit, Operating, Gross MarginsCML.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. CML.MI Health Analysis

2.1 Basic Checks

  • CML has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • CML has about the same amout of shares outstanding than it did 1 year ago.
  • The debt/assets ratio for CML has been reduced compared to a year ago.
CML.MI Yearly Shares OutstandingCML.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
CML.MI Yearly Total Debt VS Total AssetsCML.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

  • CML has an Altman-Z score of 0.75. This is a bad value and indicates that CML is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.75, CML is doing worse than 69.23% of the companies in the same industry.
  • A Debt/Equity ratio of 0.67 indicates that CML is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.67, CML perfoms like the industry average, outperforming 40.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Altman-Z 0.75
ROIC/WACC2.02
WACC7.2%
CML.MI Yearly LT Debt VS Equity VS FCFCML.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 10M -10M

2.3 Liquidity

  • A Current Ratio of 1.11 indicates that CML should not have too much problems paying its short term obligations.
  • CML has a Current ratio of 1.11. This is in the lower half of the industry: CML underperforms 71.15% of its industry peers.
  • CML has a Quick Ratio of 1.11. This is a bad value and indicates that CML is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of CML (0.36) is worse than 96.15% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.36
CML.MI Yearly Current Assets VS Current LiabilitesCML.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. CML.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 22.54% over the past year.
  • CML shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 55.98% yearly.
  • Looking at the last year, CML shows a decrease in Revenue. The Revenue has decreased by -3.02% in the last year.
  • Measured over the past years, CML shows a very strong growth in Revenue. The Revenue has been growing by 23.83% on average per year.
EPS 1Y (TTM)22.54%
EPS 3Y51.97%
EPS 5Y55.98%
EPS Q2Q%-0.7%
Revenue 1Y (TTM)-3.02%
Revenue growth 3Y41.46%
Revenue growth 5Y23.83%
Sales Q2Q%-13.6%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.72% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, CML will show a very strong growth in Revenue. The Revenue will grow by 35.30% on average per year.
EPS Next Y13.96%
EPS Next 2Y21.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year99.15%
Revenue Next 2Y51.57%
Revenue Next 3Y54.8%
Revenue Next 5Y35.3%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CML.MI Yearly Revenue VS EstimatesCML.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
CML.MI Yearly EPS VS EstimatesCML.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 0.1 0.2 0.3 0.4 0.5

More info and screens

Find the best growth stocksShow best growing peers

5

4. CML.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 14.51, which indicates a correct valuation of CML.
  • Based on the Price/Earnings ratio, CML is valued cheaper than 80.77% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.15. CML is valued slightly cheaper when compared to this.
  • CML is valuated correctly with a Price/Forward Earnings ratio of 12.57.
  • 75.00% of the companies in the same industry are more expensive than CML, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.27, CML is valued a bit cheaper.
Industry RankSector Rank
PE 14.51
Fwd PE 12.57
CML.MI Price Earnings VS Forward Price EarningsCML.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • CML's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CML is cheaper than 67.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.21
CML.MI Per share dataCML.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CML has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as CML's earnings are expected to grow with 21.72% in the coming years.
PEG (NY)1.04
PEG (5Y)0.26
EPS Next 2Y21.72%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CML.MI Dividend Analysis

5.1 Amount

  • CML does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CML.MI Fundamentals: All Metrics, Ratios and Statistics

COMAL SPA

BIT:CML (3/17/2025, 7:00:00 PM)

5.08

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners5.11%
Inst Owner ChangeN/A
Ins Owners15.28%
Ins Owner ChangeN/A
Market Cap66.50M
Revenue(TTM)59.26M
Net Income(TTM)4.13M
Analysts80
Price Target5.81 (14.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 14.51
Fwd PE 12.57
P/S 1.12
P/FCF N/A
P/OCF N/A
P/B 3.35
P/tB 3.98
EV/EBITDA 9.21
EPS(TTM)0.35
EY6.89%
EPS(NY)0.4
Fwd EY7.95%
FCF(TTM)-0.84
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS4.53
BVpS1.52
TBVpS1.28
PEG (NY)1.04
PEG (5Y)0.26
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.83%
ROE 20.81%
ROCE 23.62%
ROIC 14.56%
ROICexc 27.65%
ROICexgc 32.88%
OM 14.12%
PM (TTM) 6.97%
GM 44.47%
FCFM N/A
ROA(3y)2.62%
ROA(5y)2.89%
ROE(3y)17.19%
ROE(5y)19.48%
ROIC(3y)10.49%
ROIC(5y)12.54%
ROICexc(3y)16.97%
ROICexc(5y)17.84%
ROICexgc(3y)19.48%
ROICexgc(5y)20.06%
ROCE(3y)16.74%
ROCE(5y)19.7%
ROICexgc growth 3Y20.75%
ROICexgc growth 5Y17.56%
ROICexc growth 3Y20.8%
ROICexc growth 5Y14.05%
OM growth 3Y5.5%
OM growth 5Y21.44%
PM growth 3Y7.89%
PM growth 5Y26.25%
GM growth 3Y9.58%
GM growth 5Y17.09%
F-Score3
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Debt/EBITDA 1.34
Cap/Depr 265.47%
Cap/Sales 7.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 0.36
Altman-Z 0.75
F-Score3
WACC7.2%
ROIC/WACC2.02
Cap/Depr(3y)308.58%
Cap/Depr(5y)270.84%
Cap/Sales(3y)7.68%
Cap/Sales(5y)6.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.54%
EPS 3Y51.97%
EPS 5Y55.98%
EPS Q2Q%-0.7%
EPS Next Y13.96%
EPS Next 2Y21.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.02%
Revenue growth 3Y41.46%
Revenue growth 5Y23.83%
Sales Q2Q%-13.6%
Revenue Next Year99.15%
Revenue Next 2Y51.57%
Revenue Next 3Y54.8%
Revenue Next 5Y35.3%
EBIT growth 1Y45.55%
EBIT growth 3Y49.24%
EBIT growth 5Y50.39%
EBIT Next Year81.84%
EBIT Next 3Y44.34%
EBIT Next 5Y31.71%
FCF growth 1Y23.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y45.82%
OCF growth 3YN/A
OCF growth 5YN/A

COMAL SPA / CML.MI FAQ

Can you provide the ChartMill fundamental rating for COMAL SPA?

ChartMill assigns a fundamental rating of 4 / 10 to CML.MI.


What is the valuation status of COMAL SPA (CML.MI) stock?

ChartMill assigns a valuation rating of 3 / 10 to COMAL SPA (CML.MI). This can be considered as Overvalued.


How profitable is COMAL SPA (CML.MI) stock?

COMAL SPA (CML.MI) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for CML stock?

The Price/Earnings (PE) ratio for COMAL SPA (CML.MI) is 14.51 and the Price/Book (PB) ratio is 3.35.


Can you provide the financial health for CML stock?

The financial health rating of COMAL SPA (CML.MI) is 2 / 10.